View from the C-Suite: Franziska Katterbach, Chief Legal Officer, Khiron Life Sciences Corp. Europe, tells her company's story. Filmed on October 16, 2019

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

View from the C-Suite: Franziska Katterbach, Chief Legal Officer, Khiron Life Sciences Corp. Europe, tells her company's story. Filmed on October 16, 2019

Canada NewsWire

TORONTO, Nov. 20, 2019 /CNW/ -

The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest View from the C-Suite videos visit

About Khiron Life Sciences Corp. (TSXV: KHRN)

Khiron Life Sciences Corp. is a dynamic cannabis leader targeting a market of 620 million people in Latin America. With operations and a presence across the region, joint venture entry into the US consumer market, and expanding activity into Europe, they are a Latin American company positioned for global growth.  

Khiron Life Sciences Corp.'s cultivation capacity crosses multiple jurisdictions and with scientific research, clinical trials and education programs they are leading cannabis awareness in the region. They hold the endorsement of prominent medical associations and a network of medical clinics.

Kuida®, their innovative CBD skincare brand, is marketed widely at retail and online across Colombia, and with secure entry to additional markets in the region and the United States forms the basis of their expanding wellness unit.

About TMX Group (TSX: X)

TMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at Follow TMX Group on Twitter: @TMXGroup.

SOURCE TMX Group Limited

View original content to download multimedia:

Copyright CNW Group 2019

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).